Clinical Trial Update: Circadian Amplification in Diabetic Retinopathy [NA]

View source ↗

Summary

A clinical trial investigating circadian amplification in diabetic retinopathy (NCT06183476) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Diabetic Retinopathy | NA | Status: COMPLETED